Consistently, co-culture assays showed that B10-B11 enhances T cell cytotoxicity against dual-positive tumor cells by disrupting PD-L1 signaling, whereas monovalent B11 or controls lacking co-expression of EGFR failed to produce this effect. The gene discussed is CD274; the disease is neoplasm.